Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 09-2022 | 06-2022 | 03-2022 | 09-2021 | |
| Sales | 3,296 | 2,447 | 0 | 187,107 | 3,849 |
| Cost of Goods | 13,720 | 11,900 | N/A | 15,672 | 12,728 |
| Gross Profit | -10,423 | -9,453 | N/A | 171,435 | -8,878 |
| Operating Expenses | 6,602 | 6,655 | 0 | 6,906 | 5,835 |
| Operating Income | -16,306 | -15,208 | N/A | 165,201 | -13,986 |
| Interest Expense | 602 | 121 | 0 | 270 | 143 |
| Other Income | 937 | 1,539 | 0 | 890 | 718 |
| Pre-tax Income | -15,971 | -13,790 | 0 | 165,821 | -13,411 |
| Net Income Continuous | -15,971 | -13,790 | N/A | 165,821 | -13,411 |
| Net Income | $-15,971 | $-13,790 | $N/A | $165,821 | $-13,411 |
| EPS Basic Total Ops | -0.49 | -0.42 | N/A | 5.13 | -0.41 |
| EPS Basic Continuous Ops | -0.49 | -0.43 | N/A | 5.13 | -0.41 |
| EPS Diluted Total Ops | -0.49 | -0.42 | N/A | 5.00 | -0.41 |
| EPS Diluted Continuous Ops | -0.49 | -0.42 | N/A | 5.00 | -0.41 |
| EBITDA(a) | $-15,646 | $-15,208 | $N/A | $165,875 | $-13,986 |